Paeoniflorin exerts analgesic and hypnotic effects via adenosine A 1 receptors in a mouse neuropathic pain model

Dou Yin,Yuan-Yuan Liu,Tian-Xiao Wang,Zhen-Zhen Hu,Wei-Min Qu,Jiang-Fan Chen,Neng-Neng Cheng,Zhi-Li Huang

DOI: https://doi.org/10.1007/s00213-015-4108-6

2015-01-01

Psychopharmacology

Abstract:Rational Neuropathic pain is frequently comorbid with sleep disturbances. Paeoniflorin, a main active compound of total glucosides of paeony, has been well documented to exhibit neuroprotective bioactivity. Objective The present study evaluated effects of paeoniflorin on neuropathic pain and associated insomnia and the mechanisms involved. Methods The analgesic and hypnotic effects of paeoniflorin were measured by mechanical threshold and thermal latency, electroencephalogram (EEG) and electromyogram, and c-Fos expression in a neuropathic pain insomnia model. Results The data revealed that paeoniflorin (50 or 100 mg/kg, i.p.) significantly increased the mechanical threshold and prolonged the thermal latency in partial sciatic nerve ligation (PSNL) mice. Meanwhile, paeoniflorin increased non-rapid eye movement (NREM) sleep amount and concomitantly decreased wakefulness time. However, pretreatment with l,3-dimethy-8-cyclopenthylxanthine, an adenosine A 1 receptor (R, A 1 R) antagonist, abolished the analgesic and hypnotic effects of paeoniflorin. Moreover, paeoniflorin at 100 mg/kg failed to change mechanical threshold and thermal latency and NREM sleep in A 1 R knockout PSNL mice. Immunohistochemical study showed that paeoniflorin inhibited c-Fos overexpression induced by PSNL in the anterior cingulate cortex and ventrolateral periaqueductal gray. Conclusions The present findings indicated that paeoniflorin exerted analgesic and hypnotic effects via adenosine A 1 Rs and might be of potential use in the treatment of neuropathic pain and associated insomnia.